DOAC
Showing 26 - 50 of 167
Aortic Stenosis Trial in Oslo (Acetylsalicylic acid, Apixaban, Rivaroxaban)
Recruiting
- Aortic Stenosis
- Acetylsalicylic acid
- +3 more
-
Oslo, Norway
- +1 more
Mar 23, 2022
Post Biopsy Bleeding Trial in Shatin (Endoclip)
Recruiting
- Post Biopsy Bleeding
- Endoclip
-
Shatin, New Territories, Hong KongPrince of Wales Hospital
Mar 7, 2022
Early Surgical Fixation of Low-Velocity Hip Fractures in Direct
Recruiting
- Hip Fractures
- Early Surgical Fixation vs. Delayed Surgical Fixation
-
Vienna, AustriaMedical University of Vienna, Department of Traumatology
Jan 8, 2022
Urin-based Point-of-Care Testing for Direct Oral Anticoagulants
Recruiting
- Stroke
- Urin-based test by the DOASENSE Dipstick Device
-
Gießen, Hesse, GermanyDepartment of Neurology, University Hospital Giessen
Sep 13, 2023
Deep Vein Thrombosis, Post Thrombotic Syndrome Trial in Hamilton, Toronto (tinzaparin, Rivaroxaban)
Recruiting
- Deep Vein Thrombosis
- Post Thrombotic Syndrome
-
Hamilton, Ontario, Canada
- +2 more
May 4, 2022
Investigate if Early Atrial Fibrillation Diagnosis Reduces Risk
Recruiting
- Atrial Fibrillation
- Heart healthy Engagement Program with the Apple Watch Series 5 or later
- Anti-Coagulation Adherence Module with the Apple Watch Series 5 or later
-
San Mateo, CaliforniaEvidation Health
Mar 4, 2022
Left Atrial Appendage Closure, Thrombosis, Stroke Trial in Quebec (Rivaroxaban, dabigatran, apixaban, or edoxaban, Clopidogrel
Recruiting
- Left Atrial Appendage Closure
- +4 more
- Rivaroxaban, dabigatran, apixaban, or edoxaban
- +2 more
-
Quebec, CanadaJosep Rodes-Cabau
Jul 12, 2022
Warfarin Trial in Hong Kong (Warfarin dosage adjustment model)
Recruiting
- Warfarin
- Warfarin dosage adjustment model
-
Hong Kong, Shatin, Hong KongPrince of Wales Hospital
Nov 2, 2022
Exploratory Drug Interaction Study Between SMIs and DOACs
Recruiting
- Solid Tumor
- Cancer, Lung
-
Nijmegen, Gelderland, Netherlands
- +1 more
Feb 7, 2023
Coronary Artery Disease, Bleeding, Direct Acting Anticoagulant Adverse Reaction Trial in Italy, Spain (Direct-acting oral
Recruiting
- Coronary Artery Disease
- +2 more
- Direct-acting oral anticoagulation
-
Rozzano, Milan, Italy
- +3 more
Mar 22, 2022
Atrial Fibrillation, Recurrent Venous Thromboembolism Trial in Barcelona (dabigatran, rivaroxaban, apixaban or edoxaban)
Recruiting
- Atrial Fibrillation
- Recurrent Venous Thromboembolism
- dabigatran, rivaroxaban, apixaban or edoxaban
-
Barcelona, Catalonia, SpainHospital de la Santa Creu i Sant Pau
Apr 27, 2022
Point-of-Care Testing of Coagulation in Patients Treated With
Recruiting
- Anticoagulation With Direct Oral Anticoagulants
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Sep 2, 2021
Venous Thromboembolism, Varicose Veins Trial in London (Dalteparin Sodium, Tinzaparin Sodium, Enoxaparin Sodium)
Not yet recruiting
- Venous Thromboembolism
- Varicose Veins
- Dalteparin Sodium
- +5 more
-
London, United KingdomImperial College Hospital NHS Foundation Trust
Feb 20, 2023
NOACs in Oral and Maxillofacial Surgery: Impact on
Recruiting
- Surgery, Oral
- +5 more
- Type of surgery
- +5 more
-
Helsingborg, Sweden
- +1 more
Apr 11, 2022
Oral Anti-coagulants in Fragile Percutaneous Endoscopic
Completed
- Atrial Fibrillation
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 25, 2021
Direct Oral Anticoagulants for Treatment of Cerebral Venous
Recruiting
- Cerebral Venous Thrombosis
- Oral anticoagulant
-
Amsterdam, Noord-Holland, NetherlandsJonathan Coutinho
Feb 11, 2022
Atrial Fibrillation, Thromboembolism, Venous Trial in Roma (DOACs)
Recruiting
- Atrial Fibrillation
- Thromboembolism, Venous
-
Roma, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Feb 20, 2023
Pulmonary Embolism, Venous Thromboembolism, Atrial Fibrillation Trial in Ann Arbor (New-prescription Alert, New-prescription
Recruiting
- Pulmonary Embolism
- +2 more
- New-prescription Alert
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan
Aug 3, 2022
Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)
Recruiting
- Ischemic Stroke
- Anticoagulant Adverse Reaction
- Dabigatran, rivaroxaban, apixaban, edoxaban
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 22, 2023
Anticoagulants and Bleeding Disorders Trial in Padova (Anticoagulant drugs)
Recruiting
- Anticoagulants and Bleeding Disorders
- Anticoagulant drugs
-
Padova, ItalyGiuseppe Camporese
Sep 8, 2021
Gather Information About Rivaroxaban in United Kingdom Who Have
Completed
- Treatment of Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Multiple Locations, United KingdomMany locations
Sep 19, 2022
Curative Anticoagulants in Geriatric Perioperative Unit in
Completed
- Anticoagulants; Circulating, Hemorrhagic Disorder
- Femoral Neck Fractures
-
Nimes, FranceChu Nimes
Apr 19, 2022
Heavy Menstrual Bleeding Trial in Frankfurt am Main (Apixaban 5 MG, Rivaroxaban 20 MG, Edoxaban 60 MG)
Recruiting
- Heavy Menstrual Bleeding
- Apixaban 5 MG
- +3 more
-
Frankfurt am Main, GermanyCardioangiology Center Bethanien (CCB)
Dec 29, 2021